GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fonar Corp (NAS:FONR) » Definitions » Capex-to-Operating-Income

Fonar (FONR) Capex-to-Operating-Income : 0.03 (As of Dec. 2023)


View and export this data going back to 1981. Start your Free Trial

What is Fonar Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Fonar's Capital Expenditure for the three months ended in Dec. 2023 was $-0.13 Mil. Its Operating Income for the three months ended in Dec. 2023 was $4.89 Mil.

Hence, Fonar's Capex-to-Operating-Income for the three months ended in Dec. 2023 was 0.03.


Fonar Capex-to-Operating-Income Historical Data

The historical data trend for Fonar's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fonar Capex-to-Operating-Income Chart

Fonar Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.56 0.28 0.21 0.29

Fonar Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.53 0.28 0.01 0.03

Competitive Comparison of Fonar's Capex-to-Operating-Income

For the Diagnostics & Research subindustry, Fonar's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fonar's Capex-to-Operating-Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fonar's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Fonar's Capex-to-Operating-Income falls into.



Fonar Capex-to-Operating-Income Calculation

Fonar's Capex-to-Operating-Income for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-4.338) / 14.789
=0.29

Fonar's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.133) / 4.885
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fonar  (NAS:FONR) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Fonar Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Fonar's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Fonar (FONR) Business Description

Traded in Other Exchanges
Address
110 Marcus Drive, Melville, NY, USA, 11747
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.
Executives
Timothy Raymond Damadian director, officer: CEO, President & Treasurer 110 MARCUS DR., MELVILLE NY 11747
Luciano B Bonanni officer: Exec VP, COO & PFO 110 MARCUS DR., MELVILLE NY 11747
Raymond V Damadian director, officer: president 31 FAIRBANKS BLVD, WOODBURY NY 11797
Robert J Janoff director 32 OSAGE DRIVE, HUNTINGTON STATION NY 11746
Data Charles O director 347 LINCOLN AVENUE, BEAVER PA 15009
Claudette Chan director 145 WEST 86TH STREET, APT. 15B, NEW YORK NY 10024
David B Terry officer: Secretary BOX 1439, EAST QUOGUE NY 11942
Robert Djerejian director 303 EAST 57TH STREET, APT 16LA, NEW YORK NY 10022